Bausch Health Companies (BHC) Revenue (2009 - 2026)

Bausch Health Companies has disclosed Revenue across 18 years of filings, most recently posting $2.9 billion for Q2 2026.

• In Q2 2026, Revenue rose 12.73% year-over-year to $2.9 billion; the TTM figure through Jun 2026 stood at $10.9 billion (up 10.09% YoY), while the FY2025 annual figure was $10.3 billion, up 6.66% from the prior year.
• Revenue came in at $2.9 billion for Q2 2026 at Bausch Health Companies, up from $2.5 billion in the prior quarter.
• In the past five years, Revenue ranged from a high of $2.9 billion in Q2 2026 to a low of $1.9 billion in Q1 2022.
• Average Revenue over 5 years is $2.3 billion, with a median of $2.3 billion recorded in 2024.
• Year-over-year, Revenue retreated 6.33% in 2022 and gained 12.73% in 2026.
• Over 5 years, Revenue stood at $2.2 billion in 2022, then increased by 9.8% to $2.4 billion in 2023, then increased by 6.27% to $2.6 billion in 2024, then grew by 9.26% to $2.8 billion in 2025, then grew by 2.0% to $2.9 billion in 2026.
• Per Business Quant data, the three most recent Revenue figures were $2.9 billion in Q2 2026, $2.5 billion in Q1 2026, and $2.8 billion in Q4 2025.